BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Down 61.2% in January

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the target of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 48,200 shares, a decrease of 61.2% from the December 31st total of 124,200 shares. Based on an average trading volume of 365,000 shares, the days-to-cover ratio is currently 0.1 days.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

A number of hedge funds and other institutional investors have recently bought and sold shares of BMEZ. Oppenheimer & Co. Inc. grew its position in shares of BlackRock Health Sciences Term Trust by 0.6% in the third quarter. Oppenheimer & Co. Inc. now owns 204,354 shares of the company’s stock valued at $3,237,000 after purchasing an additional 1,153 shares during the last quarter. Brown Brothers Harriman & Co. purchased a new position in BlackRock Health Sciences Term Trust during the third quarter worth $32,000. Brown Lisle Cummings Inc. raised its holdings in shares of BlackRock Health Sciences Term Trust by 6.2% in the third quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock worth $578,000 after acquiring an additional 2,128 shares during the last quarter. Dakota Wealth Management boosted its stake in shares of BlackRock Health Sciences Term Trust by 23.4% during the third quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock valued at $357,000 after acquiring an additional 4,267 shares during the last quarter. Finally, Stifel Financial Corp lifted its holdings in BlackRock Health Sciences Term Trust by 2.2% in the 3rd quarter. Stifel Financial Corp now owns 414,346 shares of the company’s stock valued at $6,563,000 after purchasing an additional 8,843 shares in the last quarter.

BlackRock Health Sciences Term Trust Trading Down 0.7 %

BlackRock Health Sciences Term Trust stock traded down $0.12 during midday trading on Wednesday, hitting $16.40. 248,383 shares of the company’s stock were exchanged, compared to its average volume of 563,760. The firm’s 50 day simple moving average is $15.34 and its 200 day simple moving average is $15.62. BlackRock Health Sciences Term Trust has a 12-month low of $14.27 and a 12-month high of $16.59.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Friday, January 31st. Stockholders of record on Wednesday, January 15th will be paid a dividend of $0.1782 per share. The ex-dividend date of this dividend is Wednesday, January 15th. This represents a $2.14 dividend on an annualized basis and a dividend yield of 13.04%.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.